July 28, 2021
RegenMed is helping to coordinate a multi-national Circle to study the efficacy and safety of the use of platelet-rich plasma (PRP) and minimally manipulated cellular products (SVF and BMAC) for the treatment of various MSK pathologies. The initiative is spearheaded by Circle Founder, Maksim Alekseevich Strakhov, Associate Professor of the Department of Traumatology, Orthopedics and Military Field Surgery, Russian National Research Medical University, and will involve scientific and clinical collaborators from the Union State (Russia and Belarus), North America, EU, and various other regions.
Benefits of joining this Circle include:
March 28, 2023
Statistical Significance and Clinical Relevance are two important concepts in the field of medicine, and particularly in clinical research. Being a bit more specific, statistical significance refers to the likelihood that a result is not due to chance.
March 17, 2023
Real-world evidence (RWE) is valuable not only for regulatory compliance, clinical decision-making and tracking adverse events. It can also drive patient engagement, profitability and professional advancement.
January 27, 2023
In this newsletter, we summarize the work of leading physicians as they develop clinical decision support for common musculoskeletal pathologies. Through the quality improvement and pragmatic studies embedded in their Circles, those clinicians are generating sustained financial and professional value for themselves, and improving patient care, with minimum burden. Moreover, their Circles are often supported by industry.